Analysis of Plasma KIM-1 as a Biomarker for Recurrence Risk After Resection for Localized Renal Cell Carcinoma
Kidney cancer research: Analysis of plasma KIM-1 as a biomarker for recurrence risk after resection for localized renal cell carcinoma, presented by Vincent Wenxin Xu, MD at ASCO #GU21 abstract 342
Dr. Xu received his MD from Harvard Medical School in 2014. He completed residency training in internal medicine at Beth Israel Deaconess Medical Center, followed by fellowship training in hematology and medical oncology also at Beth Israel ...
